PharmaPoint: Hemophilia A and B - Current and Future Players

Jan 08, 2014, 06:19 ET from Reportlinker

NEW YORK, Jan. 8, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

PharmaPoint: Hemophilia A and B - Current and Future Players
http://www.reportlinker.com/p01937788/PharmaPoint-Hemophilia-A-and-B---Current-and-Future-Players.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

PharmaPoint: Hemophilia A and B - Current and Future Players

Summary

GlobalData has released its pharma report, "PharmaPoint: Hemophilia A and B - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Hemophilia A and B Market. The report identifies and analyses the key companies shaping and driving the global Hemophilia A and B market. The report provides insight into the competitive Hemophilia A and B landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

- Investigation of current and future market competition for Hemophilia A and B
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the Hemophilia A and B sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving the Hemophilia A and B Market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What's the next big thing in the global Hemophilia A and B market landscape? Identify, understand and capitalize

Table of Contents

1 Table of Contents 6
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 12
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers - Global Issues 17
4 Current and Future Players 20
4.1 Overview 20
4.2 Trends in Corporate Strategy 22
4.3 Company Profiles 23
4.3.1 Baxter 23
4.3.2 Biogen Idec 27
4.3.3 Novo Nordisk 29

4.3.4 CSL Behring 32
4.3.5 Bayer 33
4.3.6 Pfizer 35
5 Appendix 37
5.1 Bibliography 37
5.2 Abbreviations 39
5.3 Methodology 40
5.4 Forecasting Methodology 40
5.4.1 Diagnosed Hemophilia Patients 40
5.4.2 Percent Drug-Treated Patients 41
5.4.3 Drugs Included in Each Therapeutic Class 41
5.4.4 General Pricing Assumptions 42
5.5 Physicians and Specialists Included in this Study 43
5.6 About the Authors 45
5.6.1 Authors 45
5.6.2 Global Head of Healthcare 46
5.7 About GlobalData 47
5.8 Disclaimer 47

List of Tables

Table 1: Sales Forecasts ($m) for Hemophilia A and B in the 9MM, 2012-2022 15
Table 2: Global Hemophilia A and B Market - Drivers and Barriers, 2013 17
Table 3: Key Companies in the Hemophilia A and B Market, 2013 21
Table 4: Baxter's Hemophilia Portfolio Assessment, 2013 25
Table 5: Baxter SWOT Analysis, 2013 26
Table 6: Biogen Idec's Hemophilia Portfolio Assessment, 2013 28
Table 7: Biogen SWOT Analysis, 2013 28
Table 8: Novo Nordisk's Hemophilia Portfolio Assessment, 2013 30
Table 9: Novo Nordisk SWOT Analysis, 2013 31
Table 10: CSL Behring's Hemophilia Portfolio Assessment, 2013 32
Table 11: CSL Behring SWOT Analysis, 2013 33
Table 12: Bayer's Hemophilia Portfolio Assessment, 2013 34
Table 13: Bayer SWOT Analysis, 2013 34
Table 14: Pfizer's Hemophilia Portfolio Assessment, 2013 35
Table 15: Pfizer SWOT Analysis, 2013 36
Table 16: Abbreviations 39
Table 17: Physicians Surveyed 43

List of Figures

Figure 1: Global Sales for Hemophilia A and B by Region, 2012-2022 16
Figure 2: Company Portfolio Gap Analysis in Hemophilia A and B, 2012-2022 21

Companies Mentioned

Baxter
Biogen Idec
Novo Nordisk
CSL Behring
Bayer
Pfizer

To order this report: PharmaPoint: Hemophilia A and B - Current and Future Players
http://www.reportlinker.com/p01937788/PharmaPoint-Hemophilia-A-and-B---Current-and-Future-Players.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com